Fimasartan.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 249, doi. 10.2165/11533640-000000000-00000
- Publication type:
- Article
Works matching IS 11753277 AND DT 2011 AND VI 11 AND IP 4
Results: 7
1
2
Ambrisentan.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 215, doi. 10.2165/11207340-000000000-00000
- By:
- Publication type:
- Article
3
The Correct Administration of Antihypertensive Drugs According to the Principles of Clinical Pharmacology.
- Published in:
- 2011
- By:
- Publication type:
- Letter
4
Role of Emerging Antithrombotic Therapy in the Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 265, doi. 10.2165/11592410-000000000-00000
- By:
- Publication type:
- Article
5
Attenuation of Rate of Change in Carotid Intima-Media Thickness by Lipid-Modifying Drugs.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 253, doi. 10.2165/11591960-000000000-00000
- By:
- Publication type:
- Article
6
Fenofibrate.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 227, doi. 10.2165/11207690-000000000-00000
- By:
- Publication type:
- Article
7
Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 277, doi. 10.2165/11587160-000000000-00000
- By:
- Publication type:
- Article